Shenzhen Salubris Pharmaceuticals (SHE:002294) received approval from China's National Medical Products Administration to conduct a clinical trial for its self-developed SAL0167 tablets, according to a Thursday filing with the Shenzhen Stock Exchange.
The drug targets hypercholesterolemia or high cholesterol levels.
Shares fell nearly 4% in recent trade.
Unisem (M) (KLSE:UNISEM) received approval from Bursa Malaysia Securities Berhad to list and quote up to 161.3 million new shares under its proposed private placement, according to a Wednesday Malaysian bourse filing.Shares gained about 2% in Thursday's late morning trade.The shares represent up to 10% of the company's issued share capital.The approval is subject to customary conditions, including compliance with listing requirements and the exchange's approval conditions.
POCO Holding (SHE:300811) on Wednesday applied to issue H shares on the Main Board of the Hong Kong bourse.The listing is subject to approvals from Chinese and Hong Kong regulators, according to a Wednesday filing with the Shanghai bourse.Shares of the advanced materials manufacturer rose 3% in recent trade.
NLC India (NSE:NLCINDIA, BOM:513683) agreed to form a joint venture with National Aluminium (NSE:NATIONALUM, BOM:532234) to develop a 1,080 MW coal-based thermal captive power plant in Angul in Odisha, India, according to a Wednesday filing to the Indian stock exchanges.The 4×270 MW power plant will be set up to meet the captive power requirement of National Aluminium's 0.5 million tons per annum aluminium smelter expansion project.The joint venture, which will have equal equity participation from the two companies, will execute a fuel supply agreement with NLC India from its Machhakata coal mine or any other mines for 25 years.It will also sign a 25-year power purchase pact with National Aluminium for 100% offtake of power.